extra Flashcards

1
Q

what is the role loperamide

A

Loperamide is used to firm stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

what is the role of Ursodeoxycholic acid

A

Ursodeoxycholic acid disperses cholesterol and is used in the dissolution of gallstones and to treat primary biliary cirrhosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

role of Cholestyramine

A

Cholestyramine is used to treat itch in patients with liver disease (and also has an effect in lowering cholesterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

role of calprotectin

A

Calprotectin is a measure of gastrointestinal inflammation (think of it like CRP for the bowel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the SeHCAT scan

A

the SeHCAT scan measures bile salt reabsorption, and is a test used to investigate chronic diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what group is gallstone ileus common in and how does it present

A

Gallstone ileus is more common in the elderly and presents with evidence of small bowel obstruction (secondary to impacted calculus) –

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

chronic pancreatits symptoms vs acute pancreatitis

A

Chronic pancreatitis will have a longer history of pain, often after meals or drinking alcohol and is associated with weight loss, and malabsorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

intestinal ischacemia differentiated from acute pancreatitis

A

Ischamiea pain not relieved by sitting and is often associated with rectal bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when is MRCP useful

A

if gallstones a likely aetiology especially if the biliary tree is dilated and stones need to be demonstrated (MRCP) and removed (ERCP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is malignant ascites

A

Malignant ascites is found in patients with malignancies in the peritoneum which lead to ascites, via increased production of peritoneal fluid and concurrent decreased resorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when is bowel perforation common

A

Bowel perforation would be more likely in a patient with a known gastrointestinal disease such as Crohn’s disease or ulcerative colitis, or as a complication of bowel surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the presentation of Haemoperitoneum

A

Haemoperitoneum would be more likely following blunt or penetrating trauma, or from a ruptured blood vessel, and would unlikely be associated with a fever. Furthermore, the patient would be expected to be haemodynamically unstable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

gilbert vs NAFLD

A

Like non-alcoholic fatty liver disease, Gilbert syndrome can also present as jaundice following fasting. Indeed, dehydration, intercurrent disease, menstruation, and strenuous exertion can all trigger episodes in predisposed patients. In Gilbert syndrome, however, unconjugated bilirubin is typically elevated, whilst liver enzymes concentrations are normal. This is because Gilbert syndrome is caused by a mutation in the enzyme responsible of bilirubin conjugation with glucoronic acid (UGT1A1). When stressors increasing bilirubin production are present, UGT1A1 is overwhelmed and serum unconjugated bilirubin rises.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which disease is unlileky with a normal ferritin

A

haemochromatosis - although it should always be considered in patients with both abnormal LFTs and diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which imaging modality for bowel obstruction

A

abdominal x-ray
- may present with vomiting and constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which imaging too for large bowel pathology?

A

Colonoscopy is required to assess the large bowel for signs of pathology (e.g. in the case of bleeding, diverticulum or suspicion of colorectal cancer.)

16
Q

what is hepatorenal syndrome and how does it present?

A

a type of functional kidney impairment that occurs in patients with advanced liver disease. The key features include ascites, low urine output, and a significant increase in serum creatinine.

17
Q

first line drug for hepatorenal syndrome and mechanism?

A

Terlipressin, a vasopressin analogue, is the recommended first-line treatment for HRS according to UK guidelines. It works by inducing splanchnic vasoconstriction which reduces portal pressure and improves renal blood flow.

18
Q

Role of ocreotide

A

Octreotide is primarily used to manage variceal bleeding and certain types of tumours such as somatostatinomas and carcinoid tumours.

19
Q

Uses of propranolol (specifically in GI/Liver)

A

Propranolol typically used for primary prophylaxis against variceal bleeding in cirrhotic patients or for treating hypertension or certain arrhythmias.

20
Q

role of Acetylcysteine

A

Acetylcysteine is an antioxidant used mainly for paracetamol overdose;

21
Q

role of dopamine

A

Dopamine, while being a renal vasodilator that can theoretically improve renal perfusion, has not been found to be beneficial in the treatment of hepatorenal syndrome according to multiple clinical trials.

22
Q

which diseases do stopping smoking have most impact on in gi/liver

A

primary biliary cirrhosis and alcoholic liver disease,

23
Q

do statins help NAFLD

A

While statins can lower cholesterol levels and reduce cardiovascular risk, they have not been proven to reverse or halt the progression of NASH specifically.

24
Q

role of Sulfonylureas

A

Sulfonylureas are a class of medications used in type 2 diabetes management

25
Q

Which class of diabetic drugs can be counterproductive in NAFLD

A

Sulfonylureas - these medications could potentially exacerbate weight gain which would be counterproductive in managing NASH.

26
Q

Why should aspirin and naproxen be avoided in cirhottic patients

A

due to the risk of acute renal failure and bleeding (unless in low-dosage in patients whose cardiovascular disease risk outweighs the cirrhosis disease burden).

27
Q

when should

A